Figure 2
From: Development and characterization of agonistic antibodies targeting the Ig-like 1 domain of MuSK

MuSK agonist antibodies (partially) rescue AChR declustering induced by monovalent monoclonal MuSK antibodies or polyclonal patient IgG. (a) Outline of experimental set up. (b–d) Percentage of AChR clustering with a size larger than 15 µm2 induced by an agonist antibody or negative control antibody (Mota) with (+) or without (−) 13-3B5/b12 antibody (b), 11-3F6/b12 antibody (c) or MuSK MG polyclonal IgG (d) together with agrin. Data information: all data is normalized to the agrin only condition. Percentages of rescue are calculated with the following formula, taking the levels of negative controls in account: \(\frac{\left(agrin+inhibition+agonist\right)-\left(agrin+inhibition\right)}{agrin only-untreated}\times {100}\). For statistical analysis, an unpaired t-test with Bonferroni correction was performed to compare the different agonists versus Mota control. Statistical significance was set at *P < 0.05; **P < 0.01; ***P < 0.001. #mAb13 experiments were performed with separate untreated and Mota conditions (not displayed), the 8 datapoints of mAb13 with and without agrin + Pt Total IgG were gathered from repetitions within two experiments instead of four individual experiments.